Agilent OneSight Platform

Agilent Technologies has launched its OneSight, a new software platform designed to help researchers visualize and analyze chromosomal aneuploidies in cell-free DNA sequencing data. OneSight offers genetics laboratories a cost-effective way to perform high-quality, cell-free DNA analysis in-house, the company said. The software platform is independent of NGS sequencing technology and allows labs to set up an end-to-end cfDNA analysis pipeline. The new software was developed using expertise from Cartagenia, a company Agilent acquired last year that is known for its software solutions for variant assessment and reporting of clinical genomics data.